Green tea technology comes to market
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble names Wuxi Green Power Bio-Products exclusive Chinese licensee for solvent-free green tea processing technology, company announces Jan. 29. Green Power will use technology to manufacture green tea with high concentrations of antioxidant polyphenol for use by P&G and for sale to cosmetic, nutritional and beverage manufacturers, P&G adds. License by Green Power will mark the first time P&G and other firms will be able to use technology in cosmetics and other products. Technology involves "physical separation" rather than by chemicals, resulting in a cleaner product, P&G claims. Green Power has appointed City of Industry, Calif.-based Amax Nutritional as its exclusive North American distributor...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.